Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 231

1.

A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia.

Fleischhacker WW, McQuade RD, Marcus RN, Archibald D, Swanink R, Carson WH.

Biol Psychiatry. 2009 Mar 15;65(6):510-7. doi: 10.1016/j.biopsych.2008.07.033. Epub 2008 Nov 4.

PMID:
18986646
[PubMed - indexed for MEDLINE]
2.

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.

Chrzanowski WK, Marcus RN, Torbeyns A, Nyilas M, McQuade RD.

Psychopharmacology (Berl). 2006 Dec;189(2):259-66. Epub 2006 Oct 21.

PMID:
17058105
[PubMed - indexed for MEDLINE]
3.

A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.

McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH.

J Clin Psychiatry. 2004;65 Suppl 18:47-56.

PMID:
15600384
[PubMed - indexed for MEDLINE]
4.

A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.

Newcomer JW, Campos JA, Marcus RN, Breder C, Berman RM, Kerselaers W, L'italien GJ, Nys M, Carson WH, McQuade RD.

J Clin Psychiatry. 2008 Jul;69(7):1046-56.

PMID:
18605811
[PubMed - indexed for MEDLINE]
5.

A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia.

Kane JM, Osuntokun O, Kryzhanovskaya LA, Xu W, Stauffer VL, Watson SB, Breier A.

J Clin Psychiatry. 2009 Apr;70(4):572-81. Epub 2009 Mar 24.

PMID:
19323965
[PubMed - indexed for MEDLINE]
6.

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.

Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L'Italien G, McQuade RD, Beuzen JN.

Eur Psychiatry. 2007 Oct;22(7):433-43. Epub 2007 Jun 7.

PMID:
17555947
[PubMed - indexed for MEDLINE]
7.

Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.

Kinon BJ, Stauffer VL, Kollack-Walker S, Chen L, Sniadecki J.

J Clin Psychopharmacol. 2008 Dec;28(6):601-7. doi: 10.1097/JCP.0b013e31818aaf6c.

PMID:
19011427
[PubMed - indexed for MEDLINE]
8.

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW.

J Clin Psychiatry. 2002 Sep;63(9):763-71.

PMID:
12363115
[PubMed - indexed for MEDLINE]
9.

Aripiprazole versus olanzapine in the treatment of schizophrenia: a clinical study from India.

Jindal KC, Singh GP, Munjal V.

Int J Psychiatry Clin Pract. 2013 Feb;17(1):21-9. doi: 10.3109/13651501.2011.653376. Epub 2012 Feb 20.

PMID:
22339214
[PubMed - indexed for MEDLINE]
10.

Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.

Kane JM, Meltzer HY, Carson WH Jr, McQuade RD, Marcus RN, Sanchez R; Aripiprazole Study Group.

J Clin Psychiatry. 2007 Feb;68(2):213-23.

PMID:
17335319
[PubMed - indexed for MEDLINE]
11.

A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.

McEvoy JP, Daniel DG, Carson WH Jr, McQuade RD, Marcus RN.

J Psychiatr Res. 2007 Dec;41(11):895-905. Epub 2007 Jul 13.

PMID:
17631314
[PubMed - indexed for MEDLINE]
12.

Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia.

Ascher-Svanum H, Stensland MD, Peng X, Faries DE, Stauffer VL, Osuntokun OO, Kane JM.

Curr Med Res Opin. 2011 Jan;27(1):115-22. doi: 10.1185/03007995.2010.537594. Epub 2010 Nov 26.

PMID:
21110749
[PubMed - indexed for MEDLINE]
13.

Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.

Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG; Aripiprazole Study Group.

J Clin Psychiatry. 2003 Sep;64(9):1048-56.

PMID:
14628980
[PubMed - indexed for MEDLINE]
14.

Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.

Grootens KP, van Veelen NM, Peuskens J, Sabbe BG, Thys E, Buitelaar JK, Verkes RJ, Kahn RS.

Schizophr Bull. 2011 Mar;37(2):352-61. doi: 10.1093/schbul/sbp037. Epub 2009 Jun 19.

PMID:
19542525
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.

Glick ID, Mankoski R, Eudicone JM, Marcus RN, Tran QV, Assunção-Talbott S.

J Affect Disord. 2009 May;115(1-2):18-26. doi: 10.1016/j.jad.2008.12.017. Epub 2009 Feb 23.

PMID:
19230981
[PubMed - indexed for MEDLINE]
16.

Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.

Wang LJ, Ree SC, Huang YS, Hsiao CC, Chen CK.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:260-6. doi: 10.1016/j.pnpbp.2012.10.010. Epub 2012 Oct 18.

PMID:
23085073
[PubMed - indexed for MEDLINE]
17.

The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.

Meyer JM, Rosenblatt LC, Kim E, Baker RA, Whitehead R.

J Clin Psychiatry. 2009 Mar;70(3):318-25. Epub 2008 Dec 16.

PMID:
19192469
[PubMed - indexed for MEDLINE]
18.

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.

Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Impellizzeri C, Kaplita S, Rollin L, Iwamoto T; Aripiprazole Study Group.

J Psychopharmacol. 2006 Jul;20(4):536-46. Epub 2006 Jan 9.

PMID:
16401666
[PubMed - indexed for MEDLINE]
19.

Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.

Kwon JS, Jang JH, Kang DH, Yoo SY, Kim YK, Cho SJ; APLUS study group.

Psychiatry Clin Neurosci. 2009 Feb;63(1):73-81. doi: 10.1111/j.1440-1819.2008.01907.x.

PMID:
19154213
[PubMed - indexed for MEDLINE]
20.

A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.

Findling RL, Robb A, Nyilas M, Forbes RA, Jin N, Ivanova S, Marcus R, McQuade RD, Iwamoto T, Carson WH.

Am J Psychiatry. 2008 Nov;165(11):1432-41. doi: 10.1176/appi.ajp.2008.07061035. Epub 2008 Sep 2.

PMID:
18765484
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk